Valuation: Tellgen Corporation

Market Cap 305.45Cr 46Cr 41Cr 38Cr 34Cr 64Cr 4.32TCr 65Cr 452.52Cr 177.56Cr 2.27TCr 171.61Cr 168.04Cr 7.23TCr P/E 2024
66.3x
P/E 2025 836x
Enterprise Value 284.42Cr 43Cr 38Cr 35Cr 32Cr 60Cr 4.02TCr 61Cr 421.35Cr 165.33Cr 2.11TCr 159.79Cr 156.47Cr 6.73TCr EV / Sales 2024
4.21x
EV / Sales 2025 7.5x
Free-Float
65.03%
Yield 2024
1.06%
Yield 2025 0.54%
1 day+3.63%
1 week+2.08%
Current month-8.16%
1 month-5.95%
3 months+62.34%
6 months+13.66%
Current year+4.08%
1 week 17.74
Extreme 17.74
21.38
1 month 17.74
Extreme 17.74
22.47
Current year 11.04
Extreme 11.04
22.87
1 year 11.04
Extreme 11.04
27.46
3 years 9.94
Extreme 9.94
32.8
5 years 9.94
Extreme 9.94
42.68
10 years 9.94
Extreme 9.94
50.25
Manager TitleAgeSince
Chief Executive Officer 56 06/11/2003
Director of Finance/CFO 50 09/06/2023
Corporate Officer/Principal 44 01/04/2009
Director TitleAgeSince
Chairman 56 06/11/2003
Director/Board Member 44 09/12/2020
Director/Board Member 63 14/08/2019
Change 5-day change 1-year change 3-year change Capi.($)
+3.63%+2.08%-28.45%+5.63% 46Cr
-1.89%-2.39%-21.19%+3.85% 17TCr
-2.23%+5.67%-21.63%+12.01% 11TCr
-1.69%-1.27%-2.92%+27.96% 11TCr
+0.72%+17.79%-43.75%+5.83% 8.96TCr
-0.83%+1.27%+3.53%+80.36% 6.5TCr
-0.47%+5.71%+14.57%+81.93% 5.61TCr
+0.28%+2.89%+2.81%-24.86% 5.29TCr
-0.80%+4.63%-13.13%+29.62% 4.36TCr
+0.25%+1.56%-8.11%-13.66% 3.28TCr
Average +0.71%+4.39%-11.83%+20.87% 7.42TCr
Weighted average by Cap. +0.49%+3.58%-13.56%+20.33%

Financials

2024 2025
Net sales 44Cr 6.54Cr 5.83Cr 5.4Cr 4.88Cr 9.2Cr 617.31Cr 9.31Cr 65Cr 25Cr 324.48Cr 25Cr 24Cr 1.03TCr 36Cr 5.45Cr 4.86Cr 4.5Cr 4.07Cr 7.66Cr 514.2Cr 7.76Cr 54Cr 21Cr 270.28Cr 20Cr 20Cr 861.27Cr
Net income 3.45Cr 51.72L 46.09L 42.67L 38.62L 72.75L 49Cr 73.62L 5.12Cr 2.01Cr 26Cr 1.94Cr 1.9Cr 82Cr 35.88L 5L 5L 4L 4L 8L 5.07Cr 8L 53.15L 20.86L 2.67Cr 20.16L 19.74L 8.49Cr
Net Debt -43Cr -6.5Cr -5.8Cr -5.37Cr -4.86Cr -9.15Cr -613.72Cr -9.26Cr -64Cr -25Cr -322.59Cr -24Cr -24Cr -1.03TCr -21Cr -3.15Cr -2.81Cr -2.6Cr -2.35Cr -4.43Cr -297.28Cr -4.48Cr -31Cr -12Cr -156.26Cr -12Cr -12Cr -497.93Cr
Projected Income Statement - Annual - Tellgen Corporation
Logo Tellgen Corporation
Tellgen Corporation is a China-based company primarily engaged in the research and development, production and sales of in vitro diagnostic products. The Company's products mainly cover the fields of immunity, molecules and biochemistry, involving autoimmunity, tumors, cardiovascular, infection, hormones, metabolism and other fields. The Company's main products include tumor marker detection products, human papillomavirus (HPV) nucleic acid detection products, autoimmune disease detection products, methylation mutation detection products and other products. The Company conducts its business in the domestic and overseas markets.
Employees
683
Date Price Change Volume
21/26/21 CN¥19.14 +3.63% 2,05,74,260
20/26/20 CN¥18.47 -0.16% 1,67,52,760
19/26/19 CN¥18.50 -6.19% 2,16,62,900
16/26/16 CN¥19.72 +7.06% 3,00,23,051
15/26/15 CN¥18.42 -1.76% 2,02,83,623

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Tellgen Corporation
  1. Stock Market
  2. Stocks
  3. 300642 Stock